Processa Pharmaceuticals
PCSA
7 hedge funds and large institutions have $66.5K invested in Processa Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
2,635% more capital inflows, than outflows
Capital inflows: $5.72K | Capital outflows: $209
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.09% less ownership
Funds ownership: 1.57% → 1.49% (-0.09%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.88K |
| 2 |
Tower Research Capital (TRC)
New York
|
+$1.02K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$822 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Main Street Group
Glen Allen,
Virginia
|
-$209 |
PCSA Hedge Fund Activity: Q3 2024 in Review
7 of the 6,985 institutional investors tracked by Wall St. Rank reported a position in Processa Pharmaceuticals (PCSA) for Q3 2024, worth a combined $66.5K — down 34% from $101K a quarter earlier.
Fund positioning in PCSA was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $3.88K. The largest seller was Main Street Group, exiting entirely with an estimated $209 sold.
- 7 institutional investors held Processa Pharmaceuticals (PCSA) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $66.5K of Processa Pharmaceuticals stock for Q3 2024, down 34% quarter-over-quarter.
- 1 fund opened new Processa Pharmaceuticals positions in Q3 2024 and 1 closed out, a net change of 0 holders.
- The largest Processa Pharmaceuticals buyer in Q3 2024 was Geode Capital Management, an estimated $3.88K added.
- The largest Processa Pharmaceuticals seller in Q3 2024 was Main Street Group, an estimated $209 sold.
Based on aggregated 13F filings for Q3 2024.